Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)
Clinical trial NCT03631407 · COMPLETED
Trial details
- NCT number
- NCT03631407
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-24
- Primary completion
- 2021-06-08
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.